Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCESS: Probucol for Asymptomatic Intracranial Arterial Stenosis
ChiCTR2400091598Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of probucol in Cerebral atherosclerotic stenosis (ICAD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: New ischemic stroke events within 1 year. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
probucol
03
Conditions
Cerebral atherosclerotic stenosis (ICAD)
Beyond the preview
Go deeper on ChiCTR2400091598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091598.